Cancer Drug's hidden effects on common pills revealed
NCT ID NCT07223671
Summary
This study tested how an investigational cancer drug called repotrectinib affects the body's processing of several common medications. Researchers gave repotrectinib alongside drugs like metformin (for diabetes), digoxin (for heart conditions), and others to 30 healthy adult volunteers. The goal was to understand potential drug interactions before repotrectinib might be used with other treatments in cancer patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Local Institution - 0001
Daytona Beach, Florida, 32117-5116, United States
Conditions
Explore the condition pages connected to this study.